Oxford Instruments and GE Announce Licensing Deal
By HospiMedica staff writers
Posted on 03 Jun 2004
Oxford Instruments Superconductivity (OIS; Abingdon, UK) recently announced an agreement whereby GE Healthcare (Waukesha, WI, USA) will exclusively license in vitro rights to its proprietary dynamic nuclear polarization (DNP) technology for the creation of the world's first DNP nuclear magnetic resonance (NMR) instrument. Posted on 03 Jun 2004
Traditional NMR, although a data-rich method, has always been limited by a lack of sensitivity, causing scientists to look for alternative, and often complicated and expensive ways of tackling this hurdle.
Related Links:
Oxford Instruments Superconductivity
GE Healthcare
New
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
New
Adjustable Mobile Barrier
M-458
X-Ray Illuminator
X-Ray Viewbox Illuminators
Post-Processing Imaging System
DynaCAD Prostate
